Japan has announced its first major policy initiative to end deflation and drive a recovery from a recession since Shinzo Abe became the Prime Minister of the country on 26 December 2012.
The Abe-led Japanese government has announced plans to spend 10.3 trillion yen (around US$116bn) to increase gross domestic product (GDP), create new jobs and boost growth.
Of the total amount, nearly 3.8 trillion yen will be spent on disaster prevention and reconstruction, while another 3.1 trillion yen will be spent to stimulate private investment.
As per the Japan's Cabinet Office, additional spending will hike GDP by around 2 percentage points and generate nearly 600,000 new jobs.
But, some analysts are of the view that the new government will not pay the required heed to fiscal discipline until next elections.
Hiroaki Muto, a Tokyo-based economist with Sumitomo Mitsui Asset Management Co., said, "Abe will probably give the economy more shots in the arm and turn a blind eye to fiscal discipline until the elections."
Muto cautioned that there was a risk that long-term bond yields would jump in case Abe didn't take measures to restore fiscal health of the country.
The Japanese government will collect a 13.1 trillion yen additional budget in the current financial year to pay for its stimulus package. Some of the money will come from selling around 5 trillion yen in bonds.
According to recent rumors as well as insider tips, Microsoft will likely unveil a ‘Slim’ model of its Xbox One game console at the 2016 Electronic Entertainment Expo (E3) in Los Angeles.
The new Xbox One ‘Slim’ model will reportedly be...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an apparent attempt to enhance the visual experience for Google search users carrying out...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
Chinese device manufacturer Lenovo officially unveiled...
Motorola’s newest flagship devices -- the Moto Z and the...
In an announcement made on Thursday, electric vehicle...
The Verge has revealed in a Wednesday report, citing a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).